Skip to main content
. 2015 Jun 29;6(27):24092–24104. doi: 10.18632/oncotarget.4483

Figure 3. Evaluation of the clinincal importance of 4E-BP1 expression in CRC patients.

Figure 3

The correlation between 4E-BP1 and A. survival time and B. recurrence time were analyzed by Kaplan-Meier analysis. C. The representative of immunohistochemical staining of 4E-BP1 on different stages of sections. Left lane shows the negative staining and right lane are the positive results.